Active Cancer Biomarkers Grants

PI Name Organization - Company Titlesort descending Major Program / Research Group FOA
Weissleder, Ralph Massachusetts General Hospital Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) PAR-16-276: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
Grady, William Mallory Fred Hutchinson Cancer Center Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome RFA-CA-21-054: Translational and Basic Science Research in Early Lesions (TBEL)
Nyante, Sarah Jane Univ Of North Carolina Chapel Hill Understanding the biological basis for the association between parenchymal texture features and breast cancer risk PA-18-484: NIH Research Project Grant
Lokshin, Anna E University Of Pittsburgh At Pittsburgh Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer PA-19-056: Research Project Grant
Shu, Xiao-Ou Vanderbilt University Medical Center Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer PA-18-484: NIH Research Project Grant
Goggins, Michael G. Johns Hopkins University Using Markers to Improve Pancreatic Cancer Screening Pancreatic Cancer Detection Consortium PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Goggins, Michael G. Johns Hopkins University Using markers to improve pancreatic cancer screening and surveillance: a multi-center study Pancreatic Cancer Detection Consortium PAR-21-334: Pancreatic Cancer Detection Consortium: Research Units
Permuth, Jennifer B H. Lee Moffitt Cancer Ctr & Res Inst Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology PA-18-484: NIH Research Project Grant
Markowitz, Sanford D. Case Western Reserve University Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation Early Detection Research Network, EDRN Clinical Validation Center RFA-CA-21-033: The Early Detection Research Network: Clinical Validation Centers
Hirsch, Fred R Icahn School Of Medicine At Mount Sinai Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses COVID Serology RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence
Duncavage, Eric J Washington University Whole Genome Sequencing for Genomic Evaluation and Risk Stratification of Patients with Myelodysplastic Syndromes PAR-20-313: Assay Validation of High Quality Markers for Clinical Studies in Cancer

Pages